Four things to know:
1. The annual MedTech list honors companies that tackle surgical challenges in orthopedics.
2. Biologica’s main product, ProteiOS growth factor, is a soluble protein compound derived from the endosteum of allograft bone.
3. ProteiOS consists of a collection of growth factors, oxygenating peptides, collagen deposition peptides and cellular attachment peptides.
4. The product was initially launched for the orthopedic and neurosurgery markets.
More articles on biologics:
Dr. Adrian Park: Work-related injuries affecting orthopedic, spine surgeons & other specialists
Penn Medicine researchers seek to improve spinal discs’ early response to injury
Emory, Duke & more: 4 facilities participate in $13M clinical trial for knee stem cell treatment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
